These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prazosin alone and combined with a beta-adrenoreceptor blocker in treatment of hypertension. Gould BA; Hornung RS; Kieso HA; Cashman PM; Raftery EB J Cardiovasc Pharmacol; 1983; 5(4):678-84. PubMed ID: 6193367 [TBL] [Abstract][Full Text] [Related]
3. [Effect of alpha-methyldopa in single and divided doses on the circadian rhythm of arterial pressure in hypertensive patients]. Carpentiere G; Castello F; Marino S Clin Ter; 1984 Mar; 108(6):497-502. PubMed ID: 6233068 [No Abstract] [Full Text] [Related]
4. Effect on intra-arterial blood pressure of slow release metoprolol combined with placebo or chlorthalidone. Kieso HA; Gould BA; Mann S; Hornung RS; Altman DG; Raftery EB Br Med J (Clin Res Ed); 1983 Sep; 287(6394):717-20. PubMed ID: 6412795 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular response to isometric stress (handgrip) in patients with essential hypertension before and after antihypertensive therapy with propranolol or alpha methyldopa. Baldwa VS; Gupta BS; Chittora MD Indian Heart J; 1983; 35(6):333-6. PubMed ID: 6667950 [No Abstract] [Full Text] [Related]
6. Effect of labetalol in hypertension during exercise and postural changes. Balasubramanian V; Mann S; Millar-Craig MW; Raftery EB Br J Clin Pharmacol; 1979; 8(Suppl 2):95S-100S. PubMed ID: 526410 [TBL] [Abstract][Full Text] [Related]
7. Hemodynamic changes in long-term -methyldopa therapy of essential hypertension. Lund-Johansen P Acta Med Scand; 1972 Sep; 192(3):221-6. PubMed ID: 5055268 [No Abstract] [Full Text] [Related]
8. Effects of antihypertensive therapy on cardiovascular response to exercise. Lee WR; Fox LM; Slotkoff LM Am J Cardiol; 1979 Aug; 44(2):325-8. PubMed ID: 463771 [TBL] [Abstract][Full Text] [Related]
9. Failure of anti-hypertensive drugs to control blood pressure rise with isometric exercise in hypertension. O'Hare JA; Murnaghan DJ Postgrad Med J; 1981 Sep; 57(671):552-5. PubMed ID: 6120507 [TBL] [Abstract][Full Text] [Related]
10. The effects of alpha- and beta-adrenergic receptor blockers on the pressure responses to isometric exercise in hypertensive patients. Reuben SR; Gale EV; Blake P Br J Clin Pharmacol; 1979 Oct; 8(4):365-8. PubMed ID: 41550 [TBL] [Abstract][Full Text] [Related]
11. A comparative study of metoprolol and methyldopa in the treatment of hypertension. Karachalios GN Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553 [TBL] [Abstract][Full Text] [Related]
12. Methyldopa and neural control of circulation in essential hypertension. Mancia G; Ferrari A; Gregorini L; Bianchini C; Terzoli L; Leonetti G; Zanchetti A Am J Cardiol; 1980 Jun; 45(6):1237-43. PubMed ID: 6990740 [No Abstract] [Full Text] [Related]
14. Methyldopa and propranolol or practolol in moderate hypertension. Petrie JC; Galloway DB; Jeffers TA; Millar HR; Smith MC; Wood RA; Lewis JA; Simpson WT Br Med J; 1976 Jul; 2(6028):137-9. PubMed ID: 776350 [TBL] [Abstract][Full Text] [Related]
15. Treatment of hypertension with propranolol. Prichard BN; Gillam PM Br Med J; 1969 Jan; 1(5635):7-16. PubMed ID: 5761914 [TBL] [Abstract][Full Text] [Related]
16. Comparison of antihypertensive activity of atenolol and methyldopa at rest and during exercise. Magnani B; Ambrosioni E; Costa FV; Malini PL; Magelli C Int J Clin Pharmacol Ther Toxicol; 1981 Oct; 19(10):440-4. PubMed ID: 7287240 [TBL] [Abstract][Full Text] [Related]
17. The role of a slow channel inhibitor, verapamil, in the management of hypertension. Gould BA; Mann S; Kieso H; Subramanian VB; Raftery EB Acta Med Scand Suppl; 1984; 681():117-23. PubMed ID: 6587750 [TBL] [Abstract][Full Text] [Related]
18. The role of a slow channel inhibitor, verapamil, in the management of hypertension. Gould BA; Mann S; Kieso H; Balasubramanian V; Raftery EB Clin Exp Pharmacol Physiol Suppl; 1982; 6():113-21. PubMed ID: 6956472 [TBL] [Abstract][Full Text] [Related]